Clinical trial

Testosterone Therapy in Naturally Menopausal Women With Low Sexual Desire…

NCT00384046 · Warner Chilcott, Industry · Completed

Key facts

NCT number NCT00384046
Title Testosterone Therapy in Naturally Menopausal Women With Low Sexual Desire Receiving Transdermal Estrogen
Official title 24-Week Study to Evaluate the Efficacy/Safety of Transdermal Testosterone in Naturally Menopausal Women With Hypoactive Sexual Desire Disorder Receiving Systemic Transdermal Estrogen Therapy.
Lead sponsor Warner Chilcott, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Hypoactive Sexual Desire Disorder
Intervention type Drug
Interventions Testosterone, Placebo
Enrollment 272
Start date Nov 1, 2006
Primary completion Jul 1, 2007
Completion Jul 1, 2007
First posted Oct 4, 2006
Last update posted Apr 17, 2013
Countries Australia, Botswana, Canada, Germany, United Kingdom

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies